EFFICACY OF LONG-TERM TREATMENT WITH LURASIDONE IN CHILDREN AND ADOLESCENTS WITH BIPOLAR DEPRESSION: INTERIM ANALYSIS OF A 2-YEAR OPEN-LABEL EXTENSION STUDY

被引：0
|
作者：
DelBello, M. P. [1 ]
Goldman, R. [2 ,3 ]
Tocco, M. [2 ,3 ]
Pikalov, A. [2 ,3 ]
Deng, L. [2 ,3 ]
Cucchiaro, J. [2 ,3 ]
Loebel, A. [2 ,3 ]
机构：
[1] Univ Cincinnati, Coll Med, Dept Psychiat, Div Bipolar Disorders Res, Cincinnati, OH 45221 USA
[2] Sunov Pharmaceut, Ft Lee, NJ USA
[3] Sunov Pharmaceut, Marlborough, MA USA
来源：
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY | 2019年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：143 / 144
页数：2
相关论文
共 50 条
  • [31] Long-term treatment with darifenacin for overactive bladder: results of a 2-year, open-label extension study
    Haab, Francois
    Corcos, Jacques
    Siami, Paul
    Glavind, Karin
    Dwyer, Peter
    Steel, Michael
    Kawakami, Fernando
    Lheritier, Karine
    Steers, William D.
    [J]. BJU INTERNATIONAL, 2006, 98 (05) : 1025 - 1032
  • [32] EFFICACY AND SAFETY OF LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: INTERIM ANALYSIS OF A 24-MONTH, OPEN-LABEL EXTENSION STUDY
    Goldman, Robert
    Tocco, Michael
    Pikalov, Andrei
    Cucchiaro, Josephine
    Deng, Ling
    Loebel, Antony
    [J]. SCHIZOPHRENIA BULLETIN, 2018, 44 : S239 - S239
  • [33] Lurasidone in bipolar I depression: a 24 week, open-label extension study
    Ketter, T. A.
    Sarma, K.
    Silva, R.
    Kroger, H.
    Cucchiaro, J.
    Loebel, A.
    Grossman, F.
    Pikalov, A.
    [J]. BIPOLAR DISORDERS, 2014, 16 : 131 - 131
  • [34] Lurasidone in Bipolar I Depression: A 24 Week, Open-label Extension Study
    Ketter, Terence
    Sarma, Kaushik
    Silva, Robert
    Xu, Jane
    Cucchiaro, Josephine
    Loebel, Antony
    [J]. NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S534 - S535
  • [35] Long-term treatment with zonisamide: Results of a 2 year open-label extension study
    Wroe, S.
    Duncan, R.
    [J]. EPILEPSIA, 2006, 47 : 138 - 138
  • [36] Lurasidone in bipolar I depression: a 24 week, open-label extension study
    Ketter, T.
    Pikalov, A.
    Sarma, K.
    Silva, R.
    Kroger, H.
    Cucchiaro, J.
    Loebel, A.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S443 - S444
  • [37] Long-term efficacy and safety with zonisamide: Interim analysis of an open-label study
    Wroe, S
    Brodie, MJ
    [J]. EPILEPSIA, 2005, 46 : 118 - 118
  • [38] Long-term safety and efficacy of armodafinil in bipolar depression: A 6-month open-label extension study
    Ketter, Terence A.
    Amchin, Jess
    Frye, Mark A.
    Gross, Nicholas
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2016, 197 : 51 - 57
  • [39] Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe
    Coghill, David R.
    Banaschewski, Tobias
    Nagy, Peter
    Hernandez Otero, Isabel
    Soutullo, Cesar
    Yan, Brian
    Caballero, Beatriz
    Zuddas, Alessandro
    [J]. CNS DRUGS, 2017, 31 (07) : 625 - 638
  • [40] Cisapride in the long-term treatment of chronic gastroparesis: A 2-year open-label study
    Kendall, BJ
    Kendall, ET
    Soykan, I
    McCallum, RW
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1997, 25 (04) : 182 - 189
12345